Jim M. Koeller - Concepedia

Author

Jim M. Koeller

The University of Texas Health Science Center at San Antonio ORCID

Also Known As

J Koeller, J M Koeller, J. Koeller, J.M. Koeller, JIM KOELLER, Jim Koeller, Jim M Koeller, Jim M. Koeller, Koeller, Jim M., Oramasionwu, Christine U.

123

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio The University of Texas at Austin Austin College VA North Texas Health Care System The University of Texas Southwestern Medical Center

About

Jim M. Koeller is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1K
2	Health Sciences	5	5	120
3	Public Health	3	3	58
4	Nursing	1	1	17
5	Allied Health Professions	1	1	17

Jim M. Koeller

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A phase I trial of taxol given by a 6-hour intravenous infusion. T.D. Brown, Kathleen A. Havlin, Geoffrey R. Weiss, Journal of Clinical Oncology Pharmaceutical ScienceOncologyPhase Ii InvestigationPharmacologyClinical Trials	1991	182
Chemotherapy Given Near the End of Life by Community Oncologists for Advanced Non-Small Cell Lung Cancer Jose R. Murillo, Jim M. Koeller The Oncologist	2006	130
Antiemetic guidelines: creating a more practical treatment approach Jim M. Koeller, Matti Aapro, Richard J. Gralla, Supportive Care in Cancer MedicineSymptomatic TreatmentPatient SafetyAntiemetic GuidelinesPharmacotherapy	2002	111
Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30-minute infusion Jim M. Koeller, Donald L. Trump, Kendra D. Tutsch, Cancer ThrombopoiesisHematological MalignancyTranslational MedicineUrologyOncology	1986	88
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Angela Benson, D L Trump, Jim M. Koeller, PubMed Concurrent Iv InfusionTranslational MedicineOncologyVinca AlkaloidsPharmacology	1985	81
Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting Trevor McKibbin, Christopher R. Frei, Rebecca E. Greene, The Oncologist	2008	65
Clinical Guidelines for the Treatment of Cancer‐Related Anemia Jim M. Koeller Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	1998	62
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study M. J. Labreche, Grace C. Lee, Russell T. Attridge, The Journal of the American Board of Family Medicine	2013	60
Acute emesis: moderately emetogenic chemotherapy J�rn Herrstedt, Jim M. Koeller, Fausto Roila, Supportive Care in Cancer Hematological MalignancyMedicineHematologyOncologyAcute Emesis	2004	49
A phase I clinical trial of recombinant DNA gamma interferon. T.D. Brown, Jim M. Koeller, K Beougher, Journal of Clinical Oncology Gene TherapiesRecombinant Gamma InterferonMedicineImmunologyPharmacology	1987	46

Page 1